Kestra Medical Technologies Inc
NASDAQ:KMTS
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
K
|
Kestra Medical Technologies Inc
NASDAQ:KMTS
|
1.4B USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
190.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
181.4B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
140.5B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
139.4B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.6B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58.1B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.2B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
54.1B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.4B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37.1B USD |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Kestra Medical Technologies Inc
Glance View
Kestra Medical Technologies Ltd. operates as a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington. The company went IPO on 2025-03-06. The firm is focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies. The company has developed and commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform include the ASSURE WCD, a next generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The ASSURE WCD automatically monitors elevated risk patients and, if needed, delivers a defibrillation shock to return the patient’s heart to normal rhythm. In addition to the ASSURE WCD, its Cardiac Recovery System platform includes a comprehensive suite of fully integrated digital solutions and services.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Kestra Medical Technologies Inc is -186.9%, which is above its 3-year median of -195.4%.
Over the last 1 years, Kestra Medical Technologies Inc’s Net Margin has increased from -203.5% to -186.9%. During this period, it reached a low of -210.9% on Apr 30, 2025 and a high of -180.6% on Jan 31, 2025.